NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000272

Registered date:15/11/2005

Genome-wide case-control association study to identify susceptibility gene to diabetic nephropathy using single nucleotide polymorphisms.

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedDiabetic nephropathy
Date of first enrollment2001/06/01
Target sample size2000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeDiabetic patients with diabetic retinopathy were divided into two groups: 1) nephropathy cases (DN):-patients with overt nephropathy, 2) controls (C):-patients showing no evidence of renal dysfunction (based on the urinary albumin levels). Our first screening involved genotyping 94 DNs and 94 Cs for 10,000 SNP loci, and we further analyzed the SNP loci showing significant differences in allelic frequencies between DN and C using a larger number of patients.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients with other chronic renal diseases.

Related Information

Contact

public contact
Name Shiro Maeda
Address 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan Japan
Telephone 045-503-9595
E-mail smaeda@src.riken.jp
Affiliation SNP Research Center, RIKEN Laboratory for Diabetic Nephropathy
scientific contact
Name Shiro Maeda
Address 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan Japan
Telephone 045-503-9595
E-mail
Affiliation SNP Research Center, RIKEN Laboratory for Diabetic Nephropathy